The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee
Abstract
Dietary guidance for patients with heart failure (HF) has traditionally focused on sodium and fluid intake restriction, but dietary quality is frequently poor in patients with HF and may contribute to morbidity and mortality. Restrictive diets can lead to inadequate intake of macronutrients and micronutrients by patients with HF, with the potential for deficiencies of calcium, magnesium, zinc, iron, thiamine, vitamins D, E, and K, and folate. Although inadequate intake and low plasma levels of micronutrients have been associated with adverse clinical outcomes, evidence supporting therapeutic repletion is limited. Intravenous iron, thiamine, and coenzyme Q10 have the most clinical trial data for supplementation. There is also limited evidence supporting protein intake goals. Obesity is a risk factor for incident HF, and weight loss is an established approach for preventing HF, with a role for bariatric surgery in patients with severe obesity. However weight loss for patients with existing HF and obesity is a more controversial topic owing to an obesity survival paradox. Dietary interventions and pharmacologic weight loss therapies are understudied in HF populations. There are also limited data for optimal strategies to identify and address cachexia and sarcopenia in patients with HF, with at least 10%-20% of patients with ambulatory systolic HF developing clinically significant wasting. Gaps in our knowledge about nutrition status in patients with HF are outlined in this Statement, and strategies to address the most clinically relevant questions are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755 · cited 1×
“The updated Physical Activity Guidelines for Americans from the Department of Health and Human Services emphasize personalized exercise recommendations that support patients with chronic conditions to maximize their activity levels within the boundaries of symptom limitations.(114)”
BackgroundLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“8 mg liraglutide, although the HF end point was neutral.(55) The cardiovascular safety study of naltrexone-bupropion did not report HF outcomes, and the lorcaserin safety study showed a neutral outcome for HF at 40 months of follow-up.”
BackgroundMcClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 1×
“Nutrition and Dietetics(6) for patients with any stage of HF and from PROT-AGE (an international study group on dietary protein needs with aging).(20) However, this protein goal may not be appropriate for patients with severe CKD and is based on limited evidence.”
Background
Research works printed but not linked: 83
- Bozkurt, 2016, Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association, Circulation, 134, e535, 10.1161/CIR.0000000000000450 · DOI · Paper page
- 2010, Executive summary: HFSA 2010 comprehensive heart failure practice guideline, J Card Fail, 16, 475, 10.1016/j.cardfail.2010.04.005 · DOI · Paper page
- Ponikowski, 2016, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 · DOI · Paper page
- Yancy, 2017, J Card Fail, 23, 628, 10.1016/j.cardfail.2017.04.014 · DOI · Paper page
- 2017, Heart failure evidence-based nutritional practice guideline, Am Acad Nutr Diet, 1
- Colin-Ramirez, 2016, Changes in dietary intake and nutritional status associated with a significant reduction in sodium intake in patients with heart failure. A sub-analysis of the SODIUM-HF pilot study, Clin Nutr ESPEN, 11, e26, 10.1016/j.clnesp.2015.11.002 · DOI
- Tyson, 2012, The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations, Curr Hypertens Rep, 14, 388, 10.1007/s11906-012-0296-1 · DOI
- Mathew, 2015, Altered metabolic profile with sodium-restricted dietary approaches to stop hypertension diet in hypertensive heart failure with preserved ejection fraction, J Card Fail, 21, 963, 10.1016/j.cardfail.2015.10.003 · DOI · Paper page
- Levitan, 2013, Mediterranean and DASH diet scores and mortality in women with heart failure: the Women's Health Initiative, Circ Heart Fail, 6, 1116, 10.1161/CIRCHEARTFAILURE.113.000495 · DOI · Paper page
- Hummel, 2018, Home-delivered meals post discharge from heart failure hospitalization, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.117.004886 · DOI · Paper page
- Sze, 2018, Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index, JACC Heart Fail, 6, 476, 10.1016/j.jchf.2018.02.018 · DOI · Paper page
- Virtanen, 2018, Intake of different dietary proteins and risk of heart failure in men, Circ Heart Fail, 11, 1, 10.1161/CIRCHEARTFAILURE.117.004531 · DOI · Paper page
- Mustafa, 2018, Dietary protein and preservation of physical functioning among middle-aged and older adults in the Framingham Offspring Study, Am J Epidemiol, 187, 1411, 10.1093/aje/kwy014 · DOI
- Shetty, 2015, Micronutrient deficiencies in patients with heart failure: relationships with body mass index and age, J Card Fail, 21, 968, 10.1016/j.cardfail.2015.10.001 · DOI
- Yoshihisa, 2018, Association of serum zinc level with prognosis in patients with heart failure, J Card Fail, 24, 375, 10.1016/j.cardfail.2018.02.011 · DOI
- McKeag, 2014, The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure: a randomized, placebo-controlled trial, JACC Heart Fail, 2, 308, 10.1016/j.jchf.2013.12.008 · DOI
- Jain, 2015, Determining the role of thiamine deficiency in systolic heart failure: a meta-analysis and systematic review, J Card Fail, 21, 1000, 10.1016/j.cardfail.2015.10.005 · DOI
- Fotino, 2013, Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis, Am J Clin Nutr, 97, 268, 10.3945/ajcn.112.040741 · DOI · Paper page
- Mortensen, 2014, The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial, JACC Heart Fail, 2, 641, 10.1016/j.jchf.2014.06.008 · DOI · Paper page
- Aune, 2016, Body mass index, abdominal fatness and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies, Circulation, 133, 639, 10.1161/CIRCULATIONAHA.115.016801 · DOI · Paper page
- Ebong, 2013, The relationship between measures of obesity and incident heart failure: the Multi-Ethnic Study of Atherosclerosis, Obesity, 21, 1915, 10.1002/oby.20298 · DOI
- Pandey, 2017, Body mass index and cardiorespiratory fitness in mid-life and risk of heart failure hospitalization in older age: findings from the Cooper Center Longitudinal Study, JACC Heart Fail, 5, 367, 10.1016/j.jchf.2016.12.021 · DOI
- Carbone, 2017, Obesity and heart failure: focus on the obesity paradox, Mayo Clin Proc, 92, 266, 10.1016/j.mayocp.2016.11.001 · DOI · Paper page
- Kharod, 2013, Childhood obesity increases left-ventricular mass irrespective of blood pressure status, Pediatr Cardiol, 35, 353, 10.1007/s00246-013-0782-5 · DOI
- Gadde, 2018, Obesity, J Am Coll Cardiol, 71, 69, 10.1016/j.jacc.2017.11.011 · DOI
- Levitan, 2009, Consistency with the DASH diet and incidence of heart failure, Arch Intern Med, 169, 851, 10.1001/archinternmed.2009.56 · DOI · Paper page
- Nettleton, 2008, Incident heart failure is associated with lower whole-grain intake and greater high-fat dairy and egg intake in the Atherosclerosis Risk in Communities (ARIC) study, J Am Diet Assoc, 108, 1881, 10.1016/j.jada.2008.08.015 · DOI
- Rautiainen, 2015, Fruit and vegetable intake and rate of heart failure: a population‐based prospective cohort of women, Eur J Heart Fail, 17, 20, 10.1002/ejhf.191 · DOI
- Mechanick, 2013, Obesity, 21, S1
- Vest, 2012, Bariatric surgery and cardiovascular outcomes: a systematic review, Heart, 98, 1763, 10.1136/heartjnl-2012-301778 · DOI · Paper page
- Aggarwal, 2015, The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes, Obes Surg, 26, 1030, 10.1007/s11695-015-1866-5 · DOI · Paper page
- Sundström, 2017, Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment, Circulation, 135, 1577, 10.1161/CIRCULATIONAHA.116.025629 · DOI · Paper page
- Benotti, 2017, Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure, J Am Heart Assoc, 6, 10.1161/JAHA.116.005126 · DOI
- Persson, 2017, Risk of heart failure in obese patients with and without bariatric surgery in Sweden—a registry-based study, J Card Fail, 23, 530, 10.1016/j.cardfail.2017.05.005 · DOI
- Joyce, 2016, Heart Failure Apprentice Network. Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations, JACC Heart Fail, 4, 923, 10.1016/j.jchf.2016.09.013 · DOI
- Ndumele, 2016, N-Terminal pro–brain natriuretic peptide and heart failure risk among individuals with and without obesity: the Atherosclerosis Risk in Communities (ARIC) study, Circulation, 133, 631, 10.1161/CIRCULATIONAHA.115.017298 · DOI
- Daniels, 2006, How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly multinational study, Am Heart J, 151, 999, 10.1016/j.ahj.2005.10.011 · DOI · Paper page
- Frankenstein, 2008, Relation of N-terminal pro–brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status, Eur Heart J, 29, 2634, 10.1093/eurheartj/ehn388 · DOI
- Clark, 2014, Obesity and the obesity paradox in heart failure, Prog Cardiovasc Dis, 56, 409, 10.1016/j.pcad.2013.10.004 · DOI · Paper page
- Padwal, 2014, The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data, Int J Obes Relat Metab Disord, 38, 1110, 10.1038/ijo.2013.203 · DOI · Paper page
- Charnigo, 2016, Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice?, Heart Fail Rev, 22, 13, 10.1007/s10741-016-9577-0 · DOI
- O'Brien, 2016, Untangling the paradox: obesity as prognostic marker in prevalent cardiovascular disease, Am Heart J, 172, 170, 10.1016/j.ahj.2015.11.005 · DOI
- Mehra, 2016, The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update, J Heart Lung Transplant, 35, 1, 10.1016/j.healun.2015.10.023 · DOI · Paper page
- Khera, 2016, Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis, JAMA, 315, 2424, 10.1001/jama.2016.7602 · DOI · Paper page
- Beck-da-Silva, 2005, Effect of orlistat in obese patients with heart failure: a pilot study, Congest Heart Fail, 11, 118, 10.1111/j.1527-5299.2005.03827.x · DOI
- Jordan, 2014, Cardiovascular effects of phentermine and topiramate, J Hypertens, 32, 1178, 10.1097/HJH.0000000000000145 · DOI
- Weissman, 2013, Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials, Circ Cardiovasc Imaging, 6, 560, 10.1161/CIRCIMAGING.112.000128 · DOI
- Vest, 2016, Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction, Circ Heart Fail, 9, 10.1161/CIRCHEARTFAILURE.115.002260 · DOI
- Shimada, 2015, Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, self-controlled series, J Am Coll Cardiol, 67, 895, 10.1016/j.jacc.2015.12.016 · DOI
- Shah, 2015, Simultaneous left ventricular assist device placement and laparoscopic sleeve gastrectomy as a bridge to transplant for morbidly obese patients with severe heart failure, J Heart Lung Transplant, 34, 1489, 10.1016/j.healun.2015.06.011 · DOI
- Lim, 2016, Bariatric surgery provides a “bridge to transplant” for morbidly obese patients with advanced heart failure and may obviate the need for transplantation, Obes Surg, 26, 486, 10.1007/s11695-015-1789-1 · DOI
- Greene, 2013, Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST trial), Am J Cardiol, 111, 574, 10.1016/j.amjcard.2012.10.042 · DOI
- Kato, 2013, Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation, Am J Cardiol, 112, 1484, 10.1016/j.amjcard.2013.06.023 · DOI
- Mebazaa, 2013, Association between elevated blood glucose and outcome in acute heart failure, J Am Coll Cardiol, 61, 820, 10.1016/j.jacc.2012.11.054 · DOI
- Evans, 2008, Cachexia: a new definition, Clin Nutr, 27, 793, 10.1016/j.clnu.2008.06.013 · DOI · Paper page
- von Haehling, 2017, Muscle wasting and cachexia in heart failure: mechanisms and therapies, Nat Rev Cardiol, 14, 323, 10.1038/nrcardio.2017.51 · DOI · Paper page
- Emami, 2018, Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF), Eur J Heart Fail, 1, 4
- Christensen, 2012, Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status, Endocrine, 43, 626, 10.1007/s12020-012-9836-3 · DOI
- Hajahmadi, 2017, Muscle wasting in young patients with dilated cardiomyopathy, J Cachexia Sarcopenia Muscle, 8, 542, 10.1002/jcsm.12193 · DOI
- Russo, 2010, The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?, Ann Surg, 251, 144, 10.1097/SLA.0b013e3181b5db3c · DOI
- Alves, 2014, Comparison of two bioelectrical impedance devices and dual-energy x-ray absorptiometry to evaluate body composition in heart failure, J Hum Nutr Diet, 27, 632, 10.1111/jhn.12218 · DOI
- Heberton, 2016, Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation, Am J Cardiol, 118, 1363, 10.1016/j.amjcard.2016.07.061 · DOI
- Teigen, 2017, Preoperative pectoralis muscle quantity and attenuation by computed tomography are novel and powerful predictors of mortality after left ventricular assist device implantation, Circ Heart Fail, 10, 10.1161/CIRCHEARTFAILURE.117.004069 · DOI
- Loncar, 2016, Cardiac cachexia: hic et nunc, J Cachexia Sarcopenia Muscle, 7, 246, 10.1002/jcsm.12118 · DOI
- Kaneko, 2015, Geriatric nutritional risk index in hospitalized heart failure patients, Int J Cardiol, 181, 213, 10.1016/j.ijcard.2014.11.167 · DOI
- Khan, 2012, Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation, Circ Heart Fail, 5, 340, 10.1161/CIRCHEARTFAILURE.111.964031 · DOI
- Vest, 2016, Outcomes for patients with diabetes after continuous-flow left ventricular assist device implantation, J Card Fail, 22, 789, 10.1016/j.cardfail.2016.02.010 · DOI
- Vest, 2016, Recovery of serum cholesterol predicts survival after left ventricular assist device implantation, Circ Heart Fail, 9, 10.1161/CIRCHEARTFAILURE.115.002881 · DOI
- Ahmad, 2015, Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury, JACC Heart Fail, 3, 30, 10.1016/j.jchf.2014.06.013 · DOI
- Emani, 2013, Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device, J Heart Lung Transplant, 32, 31, 10.1016/j.healun.2012.09.024 · DOI
- Ahmad, 2016, Prognostic implications of long-chain acylcarnitines in heart failure and reversibility with mechanical circulatory support, J Am Coll Cardiol, 67, 291, 10.1016/j.jacc.2015.10.079 · DOI · Paper page
- Bonilla-Palomas, 2016, Nutritional intervention in malnourished hospitalized patients with heart failure, Arch Med Res, 47, 535, 10.1016/j.arcmed.2016.11.005 · DOI · Paper page
- Wu, 2015, Supplementation of l-alanyl-l-glutamine and fish oil improves body composition and quality of life in patients with chronic heart failure, Circ Heart Fail, 8, 1077, 10.1161/CIRCHEARTFAILURE.115.002073 · DOI
- Pineda-Juárez, 2016, Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation, Clin Nutr, 35, 41, 10.1016/j.clnu.2015.02.004 · DOI
- Giuliano, 2017, The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure—a meta-analysis, Int J Cardiol, 227, 413, 10.1016/j.ijcard.2016.11.023 · DOI · Paper page
- Tzanis, 2017, Effects of high-intensity interval exercise training on skeletal myopathy of chronic heart failure, J Card Fail, 23, 36, 10.1016/j.cardfail.2016.06.007 · DOI
- Weimann, 2017, ESPEN guideline: clinical nutrition in surgery, Clin Nutr, 36, 623, 10.1016/j.clnu.2017.02.013 · DOI · Paper page
- Evangelista, 2009, Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study, J Cardiovasc Nurs, 24, 207, 10.1097/JCN.0b013e31819846b9 · DOI
- O'Connor, 2009, Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial, JAMA, 301, 1439, 10.1001/jama.2009.454 · DOI
- Horwich, 2011, Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure, Am J Cardiol, 108, 1754, 10.1016/j.amjcard.2011.07.051 · DOI
- Pritchett, 2012, Lifestyle modification with diet and exercise in obese patients with heart failure—a pilot study, J Obes Weight Loss Ther, 2, 1, 10.4172/2165-7904.1000118 · DOI
- Ritzel, 2015, Impact of lifestyle modification on left ventricular function and cardiopulmonary exercise capacity in patients with heart failure with normal ejection fraction and cardiometabolic syndrome: a prospective interventional study, Acta Cardiol, 70, 43, 10.1080/AC.70.1.3064592 · doi:10.1080/ac.70.1.3064592
- González-Islas, 2017, The effects of a low-carbohydrate diet on oxygen saturation in heart failure patients: a randomized controlled clinical trial, Nutr Hosp, 34, 792, 10.20960/nh.784 · doi:10.20960/nh.784
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citationJaarsma, T., Hill, L., Bayes‐Genis, A., La Rocca, H. B., Castiello, T., Čelutkienė, J., Marques‐Sule, E., Plymen, C. M., Piper, S. E., Riegel, B., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2008 · Cited by 538
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., Oliveira, G. M. M. D., Simão, A. F., Dutra, O. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R. M. D. S., Giuliano, I. D. C. B., Alencar Filho, A. C. D., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 434
Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure
Hersberger, L., Dietz, A., Bürgler, H., Bargetzi, A., Bargetzi, L., Kägi-Braun, N., Tribolet, P., Gomes, F., Hoess, C., Pavlicek, V., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.232 · Cited by 168
Metadata
- Authors
- Vest, A. R., Chan, M., Deswal, A., Givertz, M. M., Lekavich, C., Lennie, T., Litwin, S. E., Parsly, L., Rodgers, J. E., Rich, M. W., Schulze, P. C., Slader, A., & Desai, A.
- Venue
- Journal of Cardiac Failure
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 25
- Issue
- 5
- Pages
- 380-400
- ISSN
- 1071-9164 (ISSN-L)
- OpenAlex
- W2921824361
- Cited by
- 230
- References
- 41
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. https://app.cochat.ai/papers/10.1016/j.cardfail.2019.03.007
- The paper
- Vest, A. R., Chan, M., Deswal, A., Givertz, M. M., Lekavich, C., Lennie, T., Litwin, S. E., Parsly, L., Rodgers, J. E., Rich, M. W., Schulze, P. C., Slader, A., & Desai, A. (2019). Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2019.03.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.